Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 789414, 10 pages
http://dx.doi.org/10.1155/2015/789414
Research Article

Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1α and NFκB Transcription Factors

Department of Molecular and Developmental Medicine, Cellular and Molecular Physiology Unit, University of Siena, 53100 Siena, Italy

Received 1 September 2015; Revised 9 November 2015; Accepted 11 November 2015

Academic Editor: Eduardo López-Collazo

Copyright © 2015 Irene Filippi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Balkwill and A. Mantovani, “Inflammation and cancer: back to Virchow?” The Lancet, vol. 357, no. 9255, pp. 539–545, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. G. Clark and D. M. Vignjevic, “Modes of cancer cell invasion and the role of the microenvironment,” Current Opinion in Cell Biology, vol. 36, pp. 13–22, 2015. View at Publisher · View at Google Scholar
  4. G. L. Semenza, “Molecular mechanisms mediating metastasis of hypoxic breast cancer cells,” Trends in Molecular Medicine, vol. 18, no. 9, pp. 534–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Mantovani, F. Marchesi, C. Porta, A. Sica, and P. Allavena, “Inflammation and cancer: breast cancer as a prototype,” Breast, vol. 16, supplement 2, pp. S27–S33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Dinarello, “Interleukin-1,” Cytokine and Growth Factor Reviews, vol. 8, no. 4, pp. 253–265, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Voronov, D. S. Shouval, Y. Krelin et al., “IL-1 is required for tumor invasiveness and angiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2645–2650, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Naldini and F. Carraro, “Role of inflammatory mediators in angiogenesis,” Current Drug Targets: Inflammation and Allergy, vol. 4, no. 1, pp. 3–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Bani, A. Garofalo, E. Scanziani, and R. Giavazzi, “Effect of interleukin-1-beta on metastasis formation in different tumor systems,” Journal of the National Cancer Institute, vol. 83, no. 2, pp. 119–123, 1991. View at Publisher · View at Google Scholar · View at Scopus
  10. E. A. Suswam, L. B. Nabors, Y. Huang, X. Yang, and P. H. King, “IL-1β induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3′ untranslated region: involvement of divergent RNA-binding factors HuR, KSRP and TIAR,” International Journal of Cancer, vol. 113, no. 6, pp. 911–919, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-J. Jung, J. S. Isaacs, S. Lee, J. Trepel, and L. Neckers, “IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis,” The FASEB Journal, vol. 17, no. 14, pp. 2115–2117, 2003. View at Google Scholar · View at Scopus
  12. G. L. Semenza, “Regulation of oxygen homeostasis by hypoxia-inducible factor 1,” Physiology, vol. 24, no. 2, pp. 97–106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Naldini, I. Filippi, D. Miglietta, M. Moschetta, R. Giavazzi, and F. Carraro, “Interleukin-1β regulates the migratory potential of MDAMB231 breast cancer cells through the hypoxia-inducible factor-1α,” European Journal of Cancer, vol. 46, no. 18, pp. 3400–3408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Dai, T. S. Lawrence, and L. Xu, “Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B,” American Journal of Translational Research, vol. 1, no. 1, pp. 1–15, 2009. View at Google Scholar · View at Scopus
  15. M. Grilli, J. J.-S. Chiu, and M. J. Lenardo, “NF-κB and Rel: participants in a multiform transcriptional regulatory system,” International Review of Cytology, vol. 143, pp. 1–62, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Tafani, E. De Santis, L. Coppola et al., “Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression,” Biomedicine & Pharmacotherapy, vol. 68, no. 1, pp. 1–5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. S. Hayden and S. Ghosh, “Signaling to NF-κB,” Genes and Development, vol. 18, pp. 2195–2224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Ruben, R. Narayanan, J. F. Klement, C.-H. Chen, and C. A. Rosen, “Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative,” Molecular and Cellular Biology, vol. 12, no. 2, pp. 444–454, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Sovak, R. E. Bellas, D. W. Kim et al., “Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 2952–2960, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Roebuck, “Regulation of interleukin-8 gene expression,” Journal of Interferon & Cytokine Research, vol. 19, no. 5, pp. 429–438, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Voss, M. F. Möller, D. G. Powe, B. Niggemann, K. S. Zänker, and F. Entschladen, “Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism,” BMC Cancer, vol. 11, article 158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Filippi, E. Morena, C. Aldinucci, F. Carraro, S. Sozzani, and A. Naldini, “Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1alpha and PI3K/Akt pathway,” Journal of Cellular Physiology, vol. 229, no. 12, pp. 2067–2076, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Vaupel, K. Schienger, C. Knoop, and M. Höckel, “Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements,” Cancer Research, vol. 51, no. 12, pp. 3316–3322, 1991. View at Google Scholar · View at Scopus
  24. L. J. Jones, M. Gray, S. T. Yue, R. P. Haugland, and V. L. Singer, “Sensitive determination of cell number using the CyQUANT cell proliferation assay,” Journal of Immunological Methods, vol. 254, no. 1-2, pp. 85–98, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Naldini, I. Filippi, E. Cini, M. Rodriquez, F. Carraro, and M. Taddei, “Downregulation of hypoxia-related responses by novel antitumor histone deacetylase inhibitors in MDAMB231 breast cancer cells,” Anti-Cancer Agents in Medicinal Chemistry, vol. 12, no. 4, pp. 407–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Naldini, I. Filippi, C. Ardinghi, A. Silini, R. Giavazzi, and F. Carraro, “Identification of a functional role for the protease-activated receptor-1 in hypoxic breast cancer cells,” European Journal of Cancer, vol. 45, no. 3, pp. 454–460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Naldini, E. Morena, A. Pucci et al., “Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1alpha and lipopolysaccharide,” Journal of Cellular Physiology, vol. 227, no. 2, pp. 587–595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, no. 7, pp. 1–12, 2002. View at Google Scholar · View at Scopus
  29. S. Singh, S. Wu, M. Varney, A. P. Singh, and R. K. Singh, “CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation,” Microvascular Research, vol. 82, no. 3, pp. 318–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Jaspers, J. M. Samet, and W. Reed, “Arsenite exposure of cultured airway epithelial cells activates kappaB-dependent interleukin-8 gene expression in the absence of nuclear factor-kappaB nuclear translocation,” The Journal of Biological Chemistry, vol. 274, no. 43, pp. 31025–31033, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Rapisarda, B. Uranchimeg, O. Sordet, Y. Pommier, R. H. Shoemaker, and G. Melillo, “Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications,” Cancer Research, vol. 64, no. 4, pp. 1475–1482, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Nieves-Neira and Y. Pommier, “Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways,” International Journal of Cancer, vol. 82, no. 3, pp. 396–404, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Dai, X.-Y. Pei, M. Rahmani, D. H. Conrad, P. Dent, and S. Grant, “Interruption of the NF-κB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells,” Blood, vol. 103, no. 7, pp. 2761–2770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Murdoch, A. Giannoudis, and C. E. Lewis, “Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues,” Blood, vol. 104, no. 8, pp. 2224–2234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Cao, M. Tanaka, C. Regnier et al., “NF-κB activation by tumor necrosis factor and interleukin-1,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 64, pp. 473–483, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-Y. Cheng, H.-L. Hsieh, C.-C. Sun, C.-C. Lin, S.-F. Luo, and C.-M. Yang, “IL-1 beta induces urokinase-plasminogen activator expression and cell migration through PKC alpha, JNK1/2, and NF-kappaB in A549 cells,” Journal of Cellular Physiology, vol. 219, no. 1, pp. 183–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Singel, K. Batten, C. Cornelius et al., “Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-κB and c-Jun N-terminal kinase pathways,” Breast Cancer Research, vol. 16, no. 2, article R28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Gabellini, D. Trisciuoglio, M. Desideri et al., “Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression,” European Journal of Cancer, vol. 45, no. 14, pp. 2618–2627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. G. L. Semenza, “Targeting HIF-1 for cancer therapy,” Nature Reviews Cancer, vol. 3, no. 10, pp. 721–732, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. P. J. Maxwell, R. Gallagher, A. Seaton et al., “HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells,” Oncogene, vol. 26, no. 52, pp. 7333–7345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Mantovani, “Molecular pathways linking inflammation and cancer,” Current Molecular Medicine, vol. 10, no. 4, pp. 369–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Mizukami, W.-S. Jo, E.-M. Duerr et al., “Induction of interleukin-8 preserves the angiogenic response in HIF-1α-deficient colon cancer cells,” Nature Medicine, vol. 11, no. 9, pp. 992–997, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. C. Scholz, M. A. S. Cavadas, M. M. Tambuwala et al., “Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 46, pp. 18490–18495, 2013. View at Publisher · View at Google Scholar · View at Scopus